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In the present study, we designed a rat model of primary hyperoxidative stress without any other structural abnormalities in order to evaluate the role of primary oxidative stress in the promotion of myocardial electrical and structural remodeling.
Methods
Glutathione-Depleted Hyperoxidative Rat Model 8-week-old Sprague-Dawley rats (CLEA Japan, Inc, Tokyo, Japan) were treated with L-buthionine-sulfoximine (BSO) (0 or 30 mmol · L -1 · day -1 , control group n=21, BSO group n=18) in drinking water for 14 days. On day 7 and/or 14, the Cardiac Remodeling in Hyperoxidative State parameters described below were evaluated and compared between the BSO-treated and control groups. All studies were performed in accordance with the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication No. 85-23, revised 1996) and the Ethics Committee of Kitasato University School of Medicine.
Heart Weight, Ratio of Heart Weight to Body Weight (HW/BW), and Blood Pressure (BP) Systolic BP was evaluated with a tail cuff and a pneumatic pulse transducer (BP-98; Softron, Tokyo, Japan). After electrophysiological measurement (see later) and before sampling the ventricular muscle, the weight of the whole heart was measured, and the ratio of HW/BW was calculated.
Histology and Evaluation of Oxidative Stress
In randomly selected rats, the heart was transversely sliced and fixed in 10% formalin, embedded in paraffin, and stained with hematoxylin-eosin for histological evaluation. Cardiac tissues were homogenized in phosphate-buffered saline solution, and interfering proteins were removed using 5% metaphosphoric acid. The tissue level of total glutathione (reduced and oxidized) in the myocardium was measured using the NWLSS TM Glutathione Assay (Northwest Life Science Specialties, LLC, Vancouver, WA, USA), and the level of total glutathione was normalized to the protein level in each sample. The serum levels of derivatives of reactive-oxygen metabolites (d-ROM) 12 were measured using the Free Radical Analytical System 4 (FRAS4; H&D srl, Parma, Italy). To analyze the oxidative damage caused to myocardial DNA, cardiac histological staining of 8-hydroxy-2'-deoxyguanosine (8OHdG) was performed using an anti-8-OHdG monoclonal antibody (N45.1; Japan Institute for the Control of Aging, Nikken Seil Co Ltd, Shizuoka, Japan).
Electrophysiological Evaluation
On day 7 or 14 after the administration of BSO, a median sternotomy was performed under interperitoneal anesthesia with tribromoethanol (240 mg/kg) and sodium pentobarbital (10-50 mg/kg) and artificial ventilation to expose the heart. The heart rate of the rats was controlled by additional intravenous anesthesia with sodium pentobarbital so that it did not exceed 400 beats/min. All measurements were performed after pharmacological blockade of the autonomic nervous system by infusion of 0.04 mg/kg atropine and 0.2 mg/kg propranolol. 13 The same system was used for the electrophysiological evaluation, as described previously. 7,14,15 A pair of platinum needle electrodes (φ0.1 mm) was used for the electrical stimulation and recording. The analog signals were converted into digital signals at a sampling frequency of 1,000 Hz (PowerLab/8SP; ADInstruments Pty Ltd, Bella Vista, NSW, Australia) and stored on a computer hard disk. The bandpass filter was set at 50-300 Hz for standard cardiac electrogram recording and at open -300 Hz for recording the monophasic action potential (MAP). To evaluate the ventricular effective refractory period (ERP) and the inducibility of ventricular arrhythmia, a single extrastimulus was delivered after 8 basic stimuli with a cycle length of 170 ms. The coupling interval of the extrastimulus was shortened in 2-ms steps until it reached ventricular refractoriness. The inducibility of ventricular arrhythmia was calculated as the ratio between the number of arrhythmias induced and the number of attempts made to induce arrhythmia during the measurement of ERP. Ventricular arrhythmia was defined as induced premature beats including a single premature beat, originating from the ventricle, which was suspected because of the QRS morphology. The MAP duration (MAPD) was determined as the interval between the onset of the MAP trace and the 20% (MAPD20) and 90% (MAPD90) repolarization times. 
Erg, ether-a-go-go-related gene; KChIP2, K + channel-interacting protein-2; L-Ca 2+ , L-type Ca 2+ channel; SERCA2a, sarcoendoplasmic reticulum Ca 2+ -ATPase 2a; NCX, Na + -Ca 2+ exchanger; RyR, ryanodine receptor; IFN-γ , interferon-γ ; TNF-α, tumor necrosis factor-α; GAPDH, glyceraldehyde-3-phosphate dehydrogenase. KUROKAWA S et al. To prepare the standard plasmids for the real-time RT-PCR, PCR was performed using the relevant primer pair ( Table 1) , and the amplified DNA was inserted into the pGEM ® -T vector (pGEM ® -T and pGEM ® -T Easy Vector Systems, Promega). The resultant recombinant plasmids were used to produce standard curves after their sequence identities had been confirmed. Real-time PCR was performed with pPCR MasterMix Plus for SYBR ® Green I (Eurogentec s.a., Seraing, Liege, Belgium) and the CFD 3240 Chromo4 TM Detection System (BioRad Lab Inc, Richmond, CA, USA). The PCR reactions were cycled 40 times according to a 3-step cycle procedure (denaturation at 95°C for 10 s, annealing at 60°C for 30 s, and extension at 72°C for 30 s) after the initial stages (50°C for Figure 1 . Evaluation of oxidative stress and histopathology. (A) BSO rats exhibited higher serum d-ROM levels, and the changes were greater on day 7 than on day 14 (control: n=6; BSO: n=8 on day 7, control: n=8, BSO: n=10 on day 14). *P<0.005 vs. control. ‡ P<0.01 vs. BSO group on day 14. (B) The level of total glutathione was normalized to the protein level in each sample. BSO rats exhibited markedly lower total glutathione levels in their cardiac tissue, and the changes were greater than on day 7 than on day 14 (control: n=4; BSO: n=5 on day 7, control: n=4, BSO: n=4 on day 14). *P<0.05 vs. control. ‡ P<0.05 vs. BSO group on day 14. (C) Hematoxylin-eosin (HE) staining (×12.5: scale bar = 2 mm, ×200: scale bar = 50 μm) and immunostaining for 8OHdG (×200: scale bar = 50 μm). HE staining showed no change in cardiac tissue after the administration of BSO. 8OHdG did not stain in the control group, but was clearly stained in the nuclei of the myocardial cells in the BSO group, and the degree of staining was higher on day 14 than on day 7. See text for discussion. BSO, L-buthionine-sulfoximine; d-ROM, derivatives of reactive oxygen metabolites; 8OHdG, 8-hydroxy-2'-deoxyguanosine. Cardiac Remodeling in Hyperoxidative State 2 min, followed by 95°C for 10 min). Standard curves were calculated with the CFD 3240 Chromo4 TM Detection System, and the absolute copy numbers of 19 species of mRNA in the samples were obtained.
Western Blot Analysis
Cardiac tissues were homogenized in ice-cold lysis buffer containing 50 mmol/L Tris-HCl (pH 7.5), 1 mmol/L EGTA, 150 mmol/L NaCl, 0.25% SDC, 1 mmol/L sodium orthovanadate, 1% Triton X-100, 2 μg/ml aprotinin, 1 mmol/L PMSF, and 5 μg/ml leupeptin. For Western blotting, 20 μg total protein were separated by 7.5% SDS-polyacrylamide gel electrophoresis and electroblotted onto a PVDF transfer membrane (Amersham Hypond TM -P, GE Healthcare UK Ltd, Little Chalfont, Buckinghamshire, UK). After being blocked with 5% nonfat milk, the membrane was incubated with anti- The expression levels of erg and SERCA2 were normalized to those of the control group.
Statistical Analysis
All values are expressed as the mean ± S.E. The basic comparative statistics were produced with 1-way ANOVA or the paired t-test. Statistical analysis was performed with JMP 6 software for Windows (SAS Institute Inc, Cary, NC, USA). A P value <0.05 was considered significant. Table 2 shows the BW, HW/BW ratio, and systolic BP data for the control and BSO groups. BW was lower in the BSO group than in the controls on days 7 and 14. The HW/BW ratio was higher in the BSO group than the controls n day 7, but not on day 14. Systolic BP showed no difference between the 2 groups. Figure 1 shows the oxidative stress and histopathology findings. Panel A shows the data for serum d-ROM. The d-ROM level was higher in the BSO group than in the controls on day 7 (410±18 vs. 297±9 U. CARR, P=0.0002) and day 14 (335±7 vs. 300±8 U. CARR, P=0.004), and the d-ROM level in the BSO group was higher on day 7 than day 14 (P=0.0058). In contrast, the levels of total glutathione/protein in the cardiac tissue of the BSO group were markedly lower than those of the controls on day 7 (1.6±0.1 vs. 14.1±0.4 mmol/g, P= 0.0127) and day 14 (2.7±0.2 vs. 16.1±1.1 mmol/g, P=0.0209) and were lower on day 7 than day 14 (P=0.0127). Panel C shows representative examples of the histological findings for each group. HE staining exhibited no obvious differences in cardiac tissue between the BSO and control groups on days 7 and 14. In contrast, 8OHdG staining revealed brown pigmented nuclei in the BSO group, indicating increased oxidative stress, which was not observed in the control group. The degree of 8OHdG staining was more prominent on day 14 than on day 7. Figure 2 shows the changes in electrophysiological parameters observed during this study. Representative traces of MAP on days 7 and 14 are shown in Figures 2A, B . In the electrophysiological study, MAPD90 was longer in the BSO group than in the controls on days 7 and 14 (day 7: 70±4 vs. 57±3 ms, P=0.0441; day 14: 76±5 vs. 55±4 ms, P=0.0163, Figure 2C ), although MAPD20 did not exhibit significant differences between the 2 groups (day 7: 16±2 vs. 15±1 ms, P=0.8541; day 14: 26±1 vs. 23±2 ms, P=0.2477, Figure 2D ). In contrast, ERP was shorter in the BSO group than in the controls, and the difference was significant on day 14 (day 14: 32±1 vs. 36±1 ms, P=0.0333, Figure 2E ). The inducibility of ventricular arrhythmia was notably higher in the BSO group than in the controls, and it was higher on day 14 than on day 7 (day 7: 22 vs. 15%, P=0.0385; day 14: 32 vs. 19%, P=0.0017, Figure 2F ). Figure 3 shows the expression levels of mRNA of cardiac ion channels, transporters, connexin 43, cytokines, and BNP. The mRNA levels of Kv4.2 and erg were downregulated in the BSO group in comparison with the controls on days 7 and 14. The level of SERCA2a was downregulated in the BSO group in comparison with the controls, but the difference was only significant on day 14. The levels of IFN-γ , TNF-α and BNP exhibited no significant differences between the BSO and control groups. Figure 4 shows the Western blot analysis results for Kv4.2, erg, SERCA2, connexin 43, and actin on days 7 and 14. Panel A shows representative bands by this analysis, and Figure 3 . Changes in mRNA expression. This figure shows the mRNA expression levels of ion channels, transporters, connexin 43, cytokines, and BNP (n=4 in each group on day 7, control: n=5, BSO: n=6 on day 14). The levels of Kv4.2 and erg were downregulated in the BSO group on days 7 and 14. The levels of SERCA2a were downregulated in the BSO group on day 14. The mRNA levels of IFN-γ, TNF-α and BNP did not differ between the 2 groups on day 7 or 14. *P<0.05 vs. control. BNP, brain natriuretic protein; BSO, L-buthionine-sulfoximine; IFN, interferon; TNF, tumor necrosis factor. Cardiac Remodeling in Hyperoxidative State Panels B -F show the mean densities of the bands for ion channels, SERCA2, connexin 43, and actin in all rats in the BSO and control groups. The expression of erg was downregulated in the BSO group in comparison with the controls on days 7 and 14. The expression of SERCA2 was downregulated in the BSO group in comparison with the controls on day 7. The densities of the Kv4.2, connexin 43, and actin bands exhibited no difference between the 2 groups in this analysis.
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Discussion
In the present study, we evaluated electrical remodeling and arrhythmia in glutathione-depleted rats, which is a model of a primary and systemic hyperoxidative state, and we have demonstrated several interesting and important findings. First, the BSO-treated rats exhibited a glutathione-depleted hyperoxidative state without demonstrating any structural changes in their cardiac tissue or elevated levels of cytokines or BNP. Second, in the BSO-treated rats, the vulnerability of the ventricles to arrhythmia was increased, together with a shortening of the ventricular ERP. Third, ventricular MAPD90 was prolonged in BSO-treated rats. Finally, the expression levels of erg and SERCA2a were downregulated in the BSO-treated rats at both the protein and mRNA levels, and the expression level of Kv4.2 was also downregulated in the BSO-treated rats but only at the mRNA level.
The BSO-Treated Rat, a Model of a Primary Systemic
Hyperoxidative State BSO inhibits γ-glutamylcysteine synthetase 8 and suppresses the glutathione system, resulting in increased levels of reactive oxygen species (ROS). In the present study, all indices of oxidative stress exhibited a hyperoxidative state after 7 or 14 days of BSO treatment, indicating that this is an appropriate model of a primary systemic hyperoxidative state. Interestingly, the serum d-ROM level was higher and the glutathione level lower on day 7 than on day 14, indicating that oxidative stress was greater on day 7 than on day 14, although 8OHdG staining seemed more prominent on day 14 than on day 7. The precise mechanisms of these results are unclear, but the findings indicate that systemic oxidative stress is decreased by the compensatory actions of other antioxidative systems such as the catalase or thioredoxin system, whereas DNA damage, as represented by 8OHdG staining, occurs progressively. Theoretically, we suggest that a reduction in total glutathione leads to a decrease in intracellular GSH, but no structural changes were documented by histology. This discrepancy may be explained by the duration of hyperoxidative stress in our protocol.
High BP 16, 17 and inflammatory cytokines such as IFN-γ 18 and TNF-α 19 are known to trigger increases in ROS expression, but their levels were not increased in the BSO-treated rats in the present study. BNP expression was not increased, and histological examinations revealed no structural abnormalities in the BSO-treated rats. Therefore, this model can be considered as an experimental model of primary hyperoxidative stress independent of any kind of disease. From another point of view, this model is also useful for evaluating the effect of oxidative stress itself, separate from the influence of other disease states.
Electrical Remodeling and Arrhythmogenicity in the Hyperoxidative State
In the electrophysiological evaluation, the inducibility of ventricular arrhythmia was higher, the ERP was shorter, and MAPD90 was longer in the BSO-treated rats in comparison with the controls. To the best of our knowledge, this is the first documentation of the electrophysiological changes and arrhythmogenicity caused by primary oxidative stress. This phenomenon can be termed "cardiac electrical remodeling" caused by hyperoxidative stress.
In previous reports, the effect of oxidative stress on the action potential duration (APD) was unclear; that is, it induced both APD shortening 20,21 and prolongation. 22, 23 Similar to previous reports, 24 our study demonstrated that MAPD90 prolongation was induced by BSO-induced oxidative stress, and this is compatible with the downregulation of erg and SERCA2a observed, because erg downregulation reduces the IKr current, resulting in delayed repolarization, and SERCA2a downregulation suppresses Ca 2+ re-absorption into the sarcoplasmic reticulum, resulting in the transient retention of Ca 2+ . However, others have documented an increase in the erg outward K + current in response to the enhancement of ROS production using the patch-clamp technique, which may result in the shortening of the APD. 25, 26 Several reports document the downregulation of Ito expression or a decrease in Ito current due to oxidative stress, 8,9,24 which is another possible explanation for APD prolongation, although the result in our study was only compatible with those reports with regard to the expression of Kv4.2 at the mRNA level.
Interestingly, ventricular ERP was shortened in the BSOtreated rats in our previous study, which seems discordant with the finding of MAPD90 prolongation. The shortening of ERP by ROS stimulation was also reported in isolated rabbit hearts, 27 and so the increase in ventricular vulnerability can be explained by considering the reentrant mechanism of ventricular arrhythmia induction. If the APD is the only determinant of ERP, this discrepancy between the changes in ERP and MAPD cannot be explained, but it has been reported that ERP is affected by other factors, such as cell-to-cell coupling 28 and tissue conductance under various autonomic nervous system tones. 29, 30 The mechanism of the ERP shortening observed in our study is unclear, but the influence of the autonomic nervous system can be ruled out because we pharmacologically blocked it. 13 The enhancement of cell-tocell coupling by oxidative stress probably plays a role in reducing cardiac tissue conductance under oxidative stress.
Study Limitations
First, the electrophysiological properties of myocardial cells could not be evaluated by the patch-clamp method because the number of living cells available for this method was extremely small, especially in the BSO-treated rats. Although the electrophysiological properties of myocardial tissue could be speculated from the changes in the MAP traces, evaluation by the patch-clamp method should be performed if possible. Second, because BSO treatment leads to a systemic hyperoxidative state, the primary and secondary effects of oxidative stress on the myocardium could not be separated. Although we excluded the influence of the autonomic nervous system by pharmacological blockade in this study, the influence of neurohumoral factors, such as inflammatory cytokines, cannot be denied. Third, evaluation of the effect of antioxidants is very important, but we could not design such a protocol because double treatment with plural medicines, especially with BSO, could not achieve stable conditions in this study. These points should be resolved in future studies using different study designs.
Conclusions
Ventricular electrical remodeling and arrhythmogenicity were evaluated in BSO-treated rats, a model of systemic hyperoxidative stress. Primary hyperoxidative stress produced electrical remodeling characterized by MAPD90 prolongation, ERP shortening, and increased ventricular vulnerability. Systemic oxidative stress might be a primary factor promoting cardiac electrophysiological remodeling independently of major organ disorders.
